2009
DOI: 10.1055/s-0028-1112148
|View full text |Cite
|
Sign up to set email alerts
|

ACE-inhibitor Suppresses the Apoptosis Induced by Endoplasmic Reticulum Stress in Renal Tubular in Experimental Diabetic Rats

Abstract: Increased tubular apoptosis in experimental diabetic rats is attenuated by blockade of the renin-angiotensin system with an ACE inhibitor, which might be in an association with reduced endoplasmic reticulum stress.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
15
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(16 citation statements)
references
References 36 publications
1
15
0
Order By: Relevance
“…These findings suggest that an angiotensin II type 1 receptor-dependent pathway contributes to the activation of ER stress and cell apoptosis (19). Recent reports also suggest that angiotensin-converting enzyme inhibitor suppresses the apoptosis induced by ER stress in renal tubules of experimental diabetic rats (40). Some may object to the numerous mechanisms of the renin-angiotensin system blockade involved in cell protection, including reversing hypoxia, ischemia and hypertension and suppressing reactive oxygen species; however, cellular stress mechanisms frequently operate through complex networks.…”
Section: O V E M B E R -D E C E M B E R 2 0 1 1 E R S T R E S S a N Dmentioning
confidence: 90%
“…These findings suggest that an angiotensin II type 1 receptor-dependent pathway contributes to the activation of ER stress and cell apoptosis (19). Recent reports also suggest that angiotensin-converting enzyme inhibitor suppresses the apoptosis induced by ER stress in renal tubules of experimental diabetic rats (40). Some may object to the numerous mechanisms of the renin-angiotensin system blockade involved in cell protection, including reversing hypoxia, ischemia and hypertension and suppressing reactive oxygen species; however, cellular stress mechanisms frequently operate through complex networks.…”
Section: O V E M B E R -D E C E M B E R 2 0 1 1 E R S T R E S S a N Dmentioning
confidence: 90%
“…in addition to the protective benefits conferred by angiotensin ii type 1 receptor (at 1 ) blockade and lowering blood pressure, angiotensin-iireceptor antagonists (or angiotensin-converting-enzyme inhibitors) have the unique ability to correct not only tissue hypoxia (by an increase in postglomerular peritubular blood flow 63 or through receptor activation of angiotensin ii type 2 receptor and no production 64 ) but also to correct oxidative stress and nitrosative stress, 65,66 carbonyl stress and advanced glycation, 67,68 redox imbalance 69 and er stress. 70 to investigate the mechanisms by which angiotensin-iireceptor antagonists confer these protective benefits, we synthesized a novel, nontoxic angiotensin-ii-receptor antagonist derivative, r-147,176, characterized by a weak affinity for the at 1 (6,700 times less effective than olmesartan in at 1 -binding inhibition), but with an ability to confer striking inhibition of oxidative stress and advanced glycation. 71 Despite a minimal effect on blood pressure, r-147,176 provided notable reno protection in two differ ent rat models of type 2 dia betes-(sHr/ nDmcr-cp and Zucker diabetic fatty rats).…”
Section: Actions Of Current Therapiesmentioning
confidence: 99%
“…The therapeutic benefi t of an RAS-inhibition in secondary prevention is partially independent of the blood pressure lowering eff ect [45] . These additional eff ects may refl ect the inhibition of angiotensin II, a potent vasoconstrictor and inductor of TGF β , VEGF and ROS generation.…”
Section: The Renin-angiotensin-system and Bradykininmentioning
confidence: 99%